Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Product Liability Law & StrategyKickerFeaturesTopicsLitigationSectionsNewsLJN Newsletters

Practice Tip: Putting a Product on Trial Without Compromising the Defense

By Peter A. Antonucci
January 27, 2011

Very often, a responsible product manufacturer will want to explore the efficacy or safety of one of its products in connection with placing it into the stream of commerce. Such a self-critical examination may occur during the research and development phase of manufacturing ' or even after the product is on the market. True candor and an unvarnished evaluation will be essential to reaching a useful conclusion. At the same time, however, wary of the ever-present threat of litigation, a prudent company does not want to create a treasure trove of discoverable materials that will have to be produced in response to even the most basic discovery requests.

Hence, the dilemma: A company will want to learn everything that can be known about the propensities of a product, but that good intention is juxtaposed against handing plaintiffs a complete dossier of who knew what, and when. From a business standpoint, the company must undertake a weighing analysis before it decides how much privileged information should be shared, or created, in connection with a self-evaluation. Critical to such a determination is an understanding of the law ' knowing exactly what is protected, and under what circumstances.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability Image

This article explores legal developments over the past year that may impact compliance officer personal liability.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.